Psychedelic Stocks

Psychedelic Stocks: MindMed and atai Slash their Pipelines, Mydecine Collapses

The psychedelic renaissance hits a rough patch as major companies look to tighten their belts or face total collapse. What’s happening with Psychedelic Stocks?
MindMed 18-MC Ibogaine Opioid Addiction

MindMed Shelves 18-MC for Opioid Use Disorder and Further Cuts Pipeline

MindMed drops its proprietary ibogaine for opioid addiction research amidst an ongoing shakeup. What is going on with this psychedelics company?
Field Trip FT-104 5-HO-DiPT

An Inside Look into Field Trip’s Next-Generation Psychedelic, FT-104

Field Trip is the only company exploring the therapeutic potential of a 4-HO-DiPT prodrug called FT-104. But how does it work?
Compass Pathways Sued

Compass Pathways Sued for Stealing Trade Secrets

Compass Pathways faces a legal challenge from Terran Biosciences over the potential theft of intellectual property
Cybin Entheon DMT Clinical TrialSutterstock

The Real Reason Cybin Bought Entheon’s DMT Clinical Trial

, ,
In a rare move Cybin aquires a phase 1 DMT clinical trial from Entheon Biomedical. CEO Doug Drysdale explains why in a Reddit AMA
TheraPsil Project Solace

Project Solace: The World’s Largest Medical Psilocybin Access and Data Project

Project Solace uses real-world data to inform development of regulated psilocybin therapy, led by Canadian non-profit TheraPsil
Microdosing clinical trialsSutterstock

3 Microdosing Clinical Trials to Keep an Eye On

Does microdosing psychedelics work, or is it the placebo effect? Here are 3 microdosing clinical trials looking for answers
Psychedelic Stocks Compass Small Pharma Mydecine Awakn

A Big Week for Psychedelic Stocks: 2 CEOs Step Down, MDMA Patents and a Phase 3 Trial

Compass Pathways and Small Pharma announce executive shakeup, Mydecine and Awakn push forward with new research
NaturoMed Therapeutics

Company Spotlight: NaturoMed Therapeutics

Canadian organic mushroom company NaturoMed Therapeutics looks to produce psilocybin in Q4 2022
Compass Pathways Appoints a New CEO

Compass Pathways Appoints a New CEO

George Goldsmith will be replaced as Compass Pathways CEO. Is this good or bad news?